News

Dr. Mark Reisman – Renowned Leader in Structural Heart Disease – Recruited to Weill Department of Medicine

Dr. Mark Reisman
The Weill Department of Medicine (WDOM) has recruited Dr. Mark Reisman, a nationally and internationally recognized authority on structural heart disease, to the Division of Cardiology. Dr. Reisman will serve as Director of Structural Heart Disease at NYP/Weill Cornell Medicine and as Co-Director of Structural Heart Disease for NYP/Queens and NYP/Brooklyn Methodist Hospital.Before joining the WDOM, Dr. Reisman served as an Attending Physician, Clinical Professor of Medicine, and was the David... Read More

Lisa Rachmuth Appointed to Executive Director of the New York City Elder Abuse Center at Weill Cornell Medicine

Lisa Rachmuth
Lisa RachmuthThe Division of Geriatrics and Palliative Medicine has announced the appointment of Lisa Rachmuth as Executive Director of the New York City Elder Abuse Center (NYCEAC), a nationally and internationally renowned program devoted to the eradication of elder abuse in collaboration with many governmental and NGO partners.Since its establishment in 2010, the NYCEAC’s leadership has been housed in the Weill Department of Medicine at Weill Cornell Medicine where faculty have made... Read More

Dr. Calfee Named Editor-in-Chief of Infection Control & Hospital Epidemiology

Dr. David Calfee
Dr. David P. CalfeeDr. David Calfee, Professor of Medicine, Division of Infectious Diseases, WDOM has been named the sixth Editor-in-Chief of the journal Infection Control & Hospital Epidemiology by The Society for Healthcare Epidemiology of America.A clinician and dedicated researcher in healthcare epidemiology, infection prevention, and antibiotic stewardship, Dr. Calfee has served as an associate editor of the journal over the past several years. He will begin to transition into his new... Read More

Findings on a Key Genetic Driver of Lymphomas Published in Nature

Dr. Ari Melnick
Dr. Ari MelnickDr. Ari Melnick, the Gebroe Family Professor of Hematology and Medical Oncology and a member of the Sandra and Edward Meyer Cancer Center at Weill Cornell, and colleagues have published breakthrough findings that show certain histone H1 mutations are drivers of lymphoma.Several years ago, Dr. Melnick and Dr. Ethel Cesarman, Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine and a pathologist at NewYork-Presbyterian/Weill Cornell, and their teams conducted... Read More

Dr. Czaja Receives M. Powell Lawton Award from the Gerontological Society of America

Dr. Sara Czaja
Dr. Sara J. CzajaDr. Sara J. Czaja, Professor of Gerontology in Medicine, Division of Geriatrics and Palliative Medicine, WDOM, has received the 2020 M. Powell Lawton Award from the Gerontological Society of America (GSA).The GSA held its Annual Scientific Meeting in November of 2020 where Dr. Czaja was honored with the prestigious award that recognizes outstanding contributions from applied gerontological research that have benefited older people and their care. The award is given to an... Read More

NIAID Renews HIV Clinical Trials Unit (CTU) Grant: Advancing Prevention and Treatment Research for HIV

Dr. Roy Gulick
Dr. Roy M. GulickDr. Roy M. Gulick, Chief, Division of Infectious Diseases, WDOM, and colleagues have received a renewal from the NIAID in support of their HIV CTU grant in the amount of $18.9 million through 2027. The renewal provides funding for both the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN).Led by Principal Investigator Dr. Gulick, the Rochelle Belfer Professor in Medicine at Weill Cornell Medicine, the research team is housed within the Weill Cornell... Read More

Dr. Scherl Receives Prestigious Rosenthal Humanitarian Award from the Crohn’s and Colitis Foundation

Crohns and Colitis Foundation "Great Gutsby" invitation
On November 12, 2020, Dr. Ellen Scherl, the Jill Roberts Professor of Inflammatory Bowel Disease, Division of Gastroenterology and Hepatology, WDOM, was honored with the Rosenthal Humanitarian Award from the Crohn’s and Colitis Foundation.Dr. Ellen ScherlPhoto credit: Nancy Scherl As part of the Crohn’s and Colitis Foundation’s 53rd Annual Gala – known as “The Great Gutsby” – Dr. Scherl’s distinguished career and pioneering advances in IBD were celebrated in a virtual event. Her outstanding... Read More

Dr. Iliev Receives Pathogenesis of Infectious Disease Award from Burroughs Wellcome Fund

Dr. Iliyan Iliev
Dr. Iliyan IlievDr. Iliyan Iliev, Associate Professor of Immunology in Medicine, Division of Gastroenterology and Hepatology, WDOM, has received the Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.The Pathogenesis of Infectious Disease Award (PATH) provides early-career scientists with $500,000 over five years to investigate the interplay between humans and pathogens, and how such encounters can lead to disease. Dr. Iliev, a scientist in the Jill... Read More

Dr. Fins Elected to President-Elect of the International Neuroethics Society

Dr. Joseph Fins
Dr. Joseph FinsOn November 12, 2020, Dr. Joseph J. Fins, Chief, Division of Medical Ethics, and E. William Davis, Jr., M.D. Professor of Medical Ethics and Professor of Medicine, WDOM, was elected to serve as President-Elect of the International Neuroethics Society, the world’s largest specialty society in neuroethics.In this new leadership role, Dr. Fins will be leading the International Neuroethics Society, a professional association of scientists, scholars, students, and practicing legal and... Read More

Dr. Rafii Wins NIH Outstanding Investigator Award: A New Era in Modern Regenerative Medicine

Dr. Shahin Rafii
Dr. Shahin Rafii, who serves as Director of the Ansary Stem Cell Institute and as Chief of the Division of Regenerative Medicine, WDOM, at Weill Cornell Medicine, has received an Outstanding Investigator Award (R35) from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The award, which will support Dr. Rafii’s project to accelerate regenerative medicine technology, provides $1 million per year (including direct and indirect costs) for seven years... Read More